Generating a novel PTPN2/N1 inhibitor using AI (IMAGE)
Caption
Insilico's compound demonstrated enhanced oral absorption, systemic exposure, and equivalent biological activities compared to the reference compound in in vitro studies.
Credit
Insilico Medicine
Usage Restrictions
none
License
Original content